Navigation Links
Cephalon Reports Another Strong Quarter
Date:10/28/2008

47,399 - 47,399

Pain 336,841 40,734 377,575

TREANDA 38,932 - 38,932

Other 14,259 70,837 85,096

Oncology 53,191 70,837 124,028

Other 37,995 117,517 155,512

$1,124,418 $284,185 $1,408,603

Nine Months Ended

September 30,

2007

United

States Europe Total

Sales:

PROVIGIL $593,394 $39,171 632,565

GABITRIL 39,814 6,268 46,082

CNS 633,208 45,439 678,647

ACTIQ 157,097 28,638 185,735

Generic OTFC 97,562 - 97,562

FENTORA 101,224 - 101,224

AMRIX - - -

Pain 355,883 28,638 384,521

TREANDA - - -

Other 13,044 56,645 69,689

Oncology 13,044 56,645 69,689

Other 40,823 114,122 154,945

$1,042,958 $244,844 $1,287,802

%'/>"/>

SOURCE Cephalon, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkins Lymphoma
9. Cephalon Presentation Slides for the 26th Annual JPMorgan Healthcare Conference Now Available
10. Cephalons EFFENTORA Receives Positive Opinion from European Regulatory Authorities for the Management of Breakthrough Cancer Pain
11. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015 GeneWEAVE, Inc ., ... announced that initial feasibility data supporting the use ... susceptibility testing from positive blood cultures will be ... 2015 in New Orleans, LA. The Company’s Smarticles™ ... that can quickly detect bacteria and assess antibiotic ...
(Date:5/29/2015)... The Academy of Model Aeronautics has awarded ... from across the nation. , The Academy of Model ... Youth Members with scholarships to pursue technical careers. Since ... awarded nearly $900,000 to college-bound aero-modelers. The scholarships are ... individuals, AMA member donations, a portion of AMA member ...
(Date:5/29/2015)... LONDON , May 29, 2015 ... forward as p ersonalized   treatments enter ... Despite generic erosion facing several of ... xinafoate), Symbicort (budesonide/formoterol fumarate) and Xolair (omalizumab), the global ... growth by the end of the decade.   ...
(Date:5/29/2015)... 29, 2015 Market Publishers Ltd ... signed a partnership agreement for quality market research ... distribute and sell research reports worked out by ... Department, commented upon the agreement: “Chem-Report is a ... petroleum and chemical markets on global and country ...
Breaking Biology Technology:Data Highlighting GeneWEAVE’s Smarticles™ Technology to be Presented at the 115th General Meeting of the American Society for Microbiology (asm2015) 2Data Highlighting GeneWEAVE’s Smarticles™ Technology to be Presented at the 115th General Meeting of the American Society for Microbiology (asm2015) 3Academy of Model Aeronautics Awards $46,500 in Scholarships to College-Bound Model Aviation Pilots 2Personalized Treatment for Severe Asthma to Drive Market Growth Despite Patent Expirations 2Personalized Treatment for Severe Asthma to Drive Market Growth Despite Patent Expirations 3Market Publishers Ltd and Chem-Report Sign Partnership Agreement 2Market Publishers Ltd and Chem-Report Sign Partnership Agreement 3
... ISLAND, S.C., Aug. 6 Denham Capital,("Denham") ... to $60 million in VitAG,Corporation ("VitAG"). VitAG ... fertilizer product capable of competing with and,outperforming ... of multiple biosolids-to-fertilizer manufacturing plants., "Denham,s ...
... Update Call on Tuesday, August 12, 2008, ... ENMD ), a clinical-stage pharmaceutical company developing,therapeutics for ... financial results for the three and six-month periods ... ), The Company reported a net loss ...
... is voluntarily recalling one manufacturing lot (P114942A) of,PROCRIT(R) (Epoetin alfa) after ... upon post-manufacturing inspection. No other lot of,this product is affected by ... configurations were distributed between,April 15, 2008 and July 17, 2008., , ... Description ...
Cached Biology Technology:Denham Capital to Invest $60 Million in VitAG, Recycler of Municipal Biosolids 2EntreMed Reports Second Quarter 2008 Financial Results 2EntreMed Reports Second Quarter 2008 Financial Results 3EntreMed Reports Second Quarter 2008 Financial Results 4EntreMed Reports Second Quarter 2008 Financial Results 5Ortho Biotech Announces Nationwide Voluntary Recall of Procrit(R) (Epoetin Alfa) Lot Number P114942A 2
(Date:5/29/2015)... , May 28, 2015 Research ... addition of the "Facial Recognition Market by ... - Global Forecast to 2020" report to ... have seen facial recognition technology become more efficient ... to gain traction and investment from the commercial ...
(Date:5/28/2015)... 2015 Industry analyst firm n-tech Research ... titled "Markets for Self-Healing Materials: 2015-2022." According to the ... vascular systems, biomaterials, relevant shape memory materials and ... billion by 2020. The report is ... smart materials. Other recent n-tech reports have included studies ...
(Date:5/27/2015)...   Codonics (codonics.com), a global ... documentation solutions and Omnicell  (omnicell.com), a ... is pleased to announce their state of ... System® (SLS), an award-winning FDA class 2 ... Anesthesia Workstation, helps prevent medication errors, streamlines ...
Breaking Biology News(10 mins):Global advanced Facial Recognition Market Expected to Grow From $2.77 Billion in 2015 to $6.19 Billion in 2020, at an Estimated CAGR of 17.4% 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4
... Independence from fossil fuel exporting nations, a reduction ... there are any number of reasons to stop the use ... probably provide the solution to our global energy problemin the ... to bioenergy. Biomass can be used to generate alternative carbon-based ...
... the Summer Olympics in Beijing kicks off today, ... of Oceanography, UC San Diego, a once-in-a-lifetime opportunity ... heavily populated region substantially curbs everyday industrial emissions. ... Experiment (CAPMEX) will include a series of flights ...
... making the grade with the,introduction of the stylish Cyber-shot(R) ... The 10-megapixel T77 camera is Sony,s thinnest model at ... x 9 touch panel LCD screen. It features,updated intelligent ... child and adult priority, as well as high,sensitivity shooting ...
Cached Biology News:Fuel from cellulose 2Scripps scientists will assess Beijing Olympics air pollution control efforts 2Scripps scientists will assess Beijing Olympics air pollution control efforts 3Sony Cyber-shot Cameras Get Smarter 2Sony Cyber-shot Cameras Get Smarter 3
... The kit for stabilizing 50g of purified ... StabMRT Plus Kit delivers all of the advantages ... but in addition the RNA can be used ... , This product has been optimised for the ...
Human SEAP ORF, provided in a pORF plasmid. pORF is an expression plasmid selectable with Ampicillin....
Plasmid expressing Zeocin resistance gene....
...
Biology Products: